[New therapeutic modalities for pulmonary disease in cystic fibrosis].
Virgilis
D
D
Augarten
A
A
Szeinberg
A
A
Yahav
Y
Y
D000584:Amiloride / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000235:genetics / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000627:therapeutic use; D003851:Deoxyribonucleases / Q000627:therapeutic use; D006801:Humans; D011480:Protease Inhibitors / Q000627:therapeutic use; D014544:Uridine Triphosphate / Q000627:therapeutic use
C505032:CFTR protein, human; D011480:Protease Inhibitors; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D000584:Amiloride; D003851:Deoxyribonucleases; D014544:Uridine Triphosphate